Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02213263 |
|---|---|
| Brief Title: | A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) |
| First Submitted : | August 7, 2014 |
| First Submitted that Met QC Criteria : | August 7, 2014 |
| First Posted : | August 11, 2014 (Estimate) |
| Results First Submitted : | October 2, 2018 |
| Results First Submitted that Met QC Criteria : | October 2, 2018 |
| Results First Posted : | October 30, 2018 |
| Last Update Submitted that Met QC Criteria : | June 18, 2019 |
| Last Update Posted : | June 20, 2019 |